Literature DB >> 385788

A rapid, inexpensive and easily quantified assay for phagocytosis and microbicidal activity of macrophages and neutrophils.

D W Simpson, R Roth, L D Loose.   

Abstract

The objective of the present study was to develop a technique to quantitate the phagocytic and intracellular microbicidal activity in different populations of phagocytes, i.e. neutrophils and macrophages. Elicited peritoneal neutrophils and macrophages as well as alveolar macrophages and adherent splenic macrophages were used as representative cell types. The method to assess intracellular killing was based upon dye uptake and concentration by a dead micro-organism; methylene blue was used as the indicator dye and the test organism was Saccharomyces cerevisiae. Phagocytosis was measured by counting, microscopically, the number of ingested yeast (Saccharomyces cerevisiae) within the neutrophils or macrophages. A number of killed yeast, i.e., those which took up the dye, were readily visualized. The temporal pattern of phagocytosis and killing was determined concurrently. Splenic macrophages demonstrated the slowest phagocytic activity whereas neutrophils and alveolar macrophages manifested a similar phagocytic activity. Peritoneal macrophages exhibited a continuous increase in activity throughout the test period. Microbicidal activity was similar for all 4 cells types. The new technique for measuring phagocytosis and killing provides a rapid, inexpensive and easily quantified assay for assessing discrete phagocytic cell functions.

Entities:  

Mesh:

Year:  1979        PMID: 385788     DOI: 10.1016/0022-1759(79)90309-0

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

1.  Biochemical and functional alterations in macrophages after thermal injury.

Authors:  L D Loose; R Megirian; J Turinsky
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

2.  The role of complement and antibody in opsonization and intracellular killing of Candida albicans.

Authors:  H A Pereira; C S Hosking
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

3.  The effects of essential fatty acid deficiency on pulmonary alveolar macrophage function.

Authors:  J A Balint; G V Karakashian; D A Beeler; R Megirian; N W Kaye
Journal:  Trans Am Clin Climatol Assoc       Date:  1985

4.  Transglutaminase 2-/- mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells.

Authors:  Zsuzsa Szondy; Zsolt Sarang; Peter Molnar; Tamas Nemeth; Mauro Piacentini; Pier Giorgio Mastroberardino; Laura Falasca; Daniel Aeschlimann; Judit Kovacs; Ildiko Kiss; Eva Szegezdi; Gabriella Lakos; Eva Rajnavolgyi; Paul J Birckbichler; Gerry Melino; Laszlo Fesus
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-16       Impact factor: 11.205

5.  Correlation between in vivo and in vitro studies of modulation of resistance to experimental Candida albicans infection by cyclophosphamide in mice.

Authors:  F Bistoni; M Baccarini; E Blasi; P Marconi; P Puccetti; E Garaci
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

6.  Intracellular acid phosphatase content and ability of different macrophage populations to kill Nocardia asteroides.

Authors:  C M Black; B L Beaman; R M Donovan; E Goldstein
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

7.  Effect of antimicrobial agents on human polymorphonuclear leukocyte microbicidal function.

Authors:  W D Welch; D Davis; L D Thrupp
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

8.  Effect of amoxycillin and doxycycline on function of human granulocytes tested in vitro and on chemotaxis of granulocytes from rabbits given the two antibiotics.

Authors:  V Grec; P C Frei
Journal:  Inflammation       Date:  1984-12       Impact factor: 4.092

9.  Environmental chemical-induced macrophage dysfunction.

Authors:  L D Loose; J B Silkworth; T Charbonneau; F Blumenstock
Journal:  Environ Health Perspect       Date:  1981-06       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.